129 related articles for article (PubMed ID: 23367274)
1. A machine learning approach using P300 responses to investigate effect of clozapine therapy.
Ravan M; MacCrimmon D; Hasey G; Reilly JP; Khodayari-Rostamabad A
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():5911-4. PubMed ID: 23367274
[TBL] [Abstract][Full Text] [Related]
2. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
[TBL] [Abstract][Full Text] [Related]
3. A Machine Learning Approach Using Effective Connectivity to Predict Response to Clozapine Treatment.
Ciprian C; Masychev K; Ravan M; Reilly JP; Maccrimmon D
IEEE Trans Neural Syst Rehabil Eng; 2020 Dec; 28(12):2598-2607. PubMed ID: 33513093
[TBL] [Abstract][Full Text] [Related]
4. Quantitative biomarkers to predict response to clozapine treatment using resting EEG data.
Masychev K; Ciprian C; Ravan M; Manimaran A; Deshmukh A
Schizophr Res; 2020 Sep; 223():289-296. PubMed ID: 32928617
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy.
Khodayari-Rostamabad A; Hasey GM; Maccrimmon DJ; Reilly JP; de Bruin H
Clin Neurophysiol; 2010 Dec; 121(12):1998-2006. PubMed ID: 21035741
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia.
Schneider C; Corrigall R; Hayes D; Kyriakopoulos M; Frangou S
Eur Psychiatry; 2014 Jan; 29(1):1-10. PubMed ID: 24119631
[TBL] [Abstract][Full Text] [Related]
7. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.
Kinoshita M; Numata S; Tajima A; Yamamori H; Yasuda Y; Fujimoto M; Watanabe S; Umehara H; Shimodera S; Nakazawa T; Kikuchi M; Nakaya A; Hashimoto H; Imoto I; Hashimoto R; Ohmori T
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335437
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
Sriretnakumar V; Huang E; Müller DJ
Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
[TBL] [Abstract][Full Text] [Related]
9. Advanced Signal Processing Methods for Characterization of Schizophrenia.
Masychev K; Ciprian C; Ravan M; Reilly JP; MacCrimmon D
IEEE Trans Biomed Eng; 2021 Apr; 68(4):1123-1130. PubMed ID: 33656984
[TBL] [Abstract][Full Text] [Related]
10. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
11. Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT
López Hill X; Richeri A; Scorza MC
Physiol Behav; 2017 Oct; 179():346-352. PubMed ID: 28705535
[TBL] [Abstract][Full Text] [Related]
12. The clinical correlation and predictive value of electrophysiological variables on clinical response to clozapine in patients with treatment-resistant schizophrenia.
Gica S; Buyukavsar A; Poyraz BC; Gulec H
Schizophr Res; 2019 Sep; 211():108-110. PubMed ID: 31331783
[No Abstract] [Full Text] [Related]
13. Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task.
Prus AJ; Philibin SD; Pehrson AL; Porter JH
Behav Pharmacol; 2005 Nov; 16(7):511-20. PubMed ID: 16170228
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity.
Williams HJ; Zamzow CR; Robertson H; Dursun SM
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):239-43. PubMed ID: 16303224
[TBL] [Abstract][Full Text] [Related]
15. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.
Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A
J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837
[TBL] [Abstract][Full Text] [Related]
16. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
[TBL] [Abstract][Full Text] [Related]
17. Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients--a preliminary study.
Kang UG; Par KT; Ahn YM; Koo YJ; Yoon SC; Yi SH; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1229-39. PubMed ID: 11474842
[TBL] [Abstract][Full Text] [Related]
18. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
Korostenskaja M; Kähkönen S
Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
[TBL] [Abstract][Full Text] [Related]
19. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
Abekawa T; Ito K; Koyama T
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
[TBL] [Abstract][Full Text] [Related]
20. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
